Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33654577)
Watch
English
The role of chemotherapy for metastatic breast cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
review article
1 reference
stated in
Europe PubMed Central
title
The role of chemotherapy for metastatic breast cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
breast cancer
1 reference
based on heuristic
inferred from title
author name string
Miller KD
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
Sledge GW Jr
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
publication date
1 April 1999
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
published in
Hematology / Oncology Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
volume
13
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
issue
2
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
page(s)
415-434
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
cites work
Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Strategies for prevention of anthracycline cardiotoxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
First-line chemotherapy of advanced breast cancer with mitoxantrone, cyclophosphamide and vincristine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Advanced breast cancer: a phase II trial with gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-response in the treatment of breast cancer: a critical review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The importance of dose intensity in chemotherapy of metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer statistics, 1998.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patterns of occurrence of second primary non-mammary malignancies in breast cancer patients: results from 1382 consecutive autopsies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer statistics, 1997.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epirubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel (taxol)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970063-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8588(05)70063-0
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
PubMed ID
10363138
1 reference
stated in
Europe PubMed Central
PubMed ID
10363138
retrieved
28 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit